ScandiDos’ Delta Discover Secures FDA Clearance
Sweden-based ScandiDos has won FDA clearance for Delta Discover, an in-vivo dosimetry system that verifies radiation dose delivered to a patient during treatment.
Delta Discover is the first device that independently verifies all dosage delivery parameters.
“It brings a new level of precision to dosimetry technology for cancer radiation therapy, and the FDA clearance paves the way for ScandiDos to make this new technology available to our U.S. customers,” said Görgen Nilsson, CEO at ScandiDos. — Anisa Jibrell